High expression of PI3 is significantly associated with poor prognosis of high-grade serous ovarian and breast cancer, and in vitro and in vivo studies have demonstrated that overexpression of PI3 promotes the proliferation of breast cancer [31, 32]. This evidence concerns the gene PI3 and breast cancer.